Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that 'COVID toes' are due to the immune reaction to SARS-CoV-2
J Eur Acad Dermatol Venereol
.
2021 Oct;35(10):e630-e632.
doi: 10.1111/jdv.17451.
Epub 2021 Jun 30.
Authors
C Lesort
1
,
J Kanitakis
1
2
,
L Donzier
1
,
D Jullien
1
Affiliations
1
Dermatology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.
2
Department of Anatomic Pathology, Lyon Sud Hospital Center, Pierre Bénite, France.
PMID:
34131969
PMCID:
PMC8447428
DOI:
10.1111/jdv.17451
No abstract available
Publication types
Case Reports
Letter
MeSH terms
BNT162 Vaccine
COVID-19 Vaccines
COVID-19*
Chilblains* / genetics
Humans
RNA, Messenger
SARS-CoV-2
Toes
Substances
COVID-19 Vaccines
RNA, Messenger
BNT162 Vaccine